TORONTO, March 4, 2020 /PRNewswire/ — Field Trip Health Inc., a wholly owned subsidiary of Field Trip Psychedelics Inc., (“Field Trip” or the “Company“), the world’s first mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, today announced the opening of its first medical centre, in Toronto, dedicated exclusively to the administration of psychedelic-enhanced psychotherapy.
The clinic was founded in response to the urgent need to combat the spiraling mental health crisis facing Canada and the world, which is a result of the limited effectiveness of current pharmacologic treatments like antidepressants. The first psychedelic that will be administered to patients, in conjunction with Field Trip’s custom developed psychotherapy protocol, is ketamine. Evidence shows that ketamine, which is a dissociative psychedelic, is safe and can provide almost immediate and enduring relief from depression symptoms. Beyond its antidepressant effects, ketamine’s ability to promote neuroplasticity makes it a powerful tool to pair with Field Trip’s comprehensive psychotherapy program.
“Multiple evidence-based studies from world-class institutions like New York University and Johns Hopkins have demonstrated that using psychedelics and psychedelic-enhanced psychotherapy can have profound, sustained results in as little as one session in addition to having positive side effects such as improved well-being, optimism and increased neural plasticity,” said Dr. Michael Verbora, Field Trip Health’s Canadian Medical Director. “Ketamine has been identified by the former Director of the National Institute of Mental Health as one of the most important breakthroughs in antidepressant treatment in decades. As new molecules or classic psychedelics like psilocybin, LSD and MDMA get approved or legalized, we will begin to incorporate them into the practice as well.”
The Toronto centre was custom designed to offer a welcoming, world-class experience to demonstrate first-hand how psychedelics can profoundly transform the lives of patients and current approaches to mental health and wellness treatment.
“Set and setting play an instrumental role in maximizing the therapeutic experience of psychedelic-enhanced psychotherapy,” adds Ronan Levy, Executive Chairman of Field Trip. “For that reason, we have invested heavily in designing a centre that is bright and welcoming. Not only is our Toronto location an inviting space for psychedelic-enhanced psychotherapy, we believe it is one of the most beautiful medical clinics in Canada.”
Psychiatrists at the clinic have begun conducting initial consultations and the first patients to experience a ketamine experience will be seen shortly.
The clinic is located at 30 Duncan St., Suite 400, Toronto, ON, M5V 2C3, Canada and patients can book a consultation by phone (1-833-222-0084), email (hi@fieldtriphealth.com) or online at https://fieldtriphealth.com/#contact
About Field Trip Psychedelics Inc.
Field Trip is the world’s first mental wellness company at the forefront of the scientific re-emergence of psychedelics and psychedelic-enhanced therapies. With Field Trip Health centres opening across North America, and advanced research on plant-based psychedelics through Field Trip Discovery, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.
Learn more at https://fieldtriphealth.com and https://fieldtripdiscovery.com
SOURCE Field Trip Psychedelics Inc.